Otogenetics corporation:1186613 [20-003576]

Ended Purchase Order Awarded Last action

Contract number
75N92B20P00047
Awardee
Awarding agency
Obligated
$24,837

Award facts

Contract value 100% obligated
$24,837.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Dunwoody, GA 30360, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a purchase order to Otogenetics Corporation valued at $24,837.00 on August 11, 2020, with final completion on August 18, 2020. The order is firm fixed price with no set-aside. Work is performed in Dunwoody, Georgia. Otogenetics provides next-generation sequencing laboratory services, including whole exome sequencing and clinical genetic testing in support of NIH research programs focused on arthritis, musculoskeletal disorders, and skin diseases.

Quick answers

Who was awarded contract 75N92B20P00047?

75N92B20P00047 was awarded to Otogenetics Corporation by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on August 11, 2020.

How much is contract 75N92B20P00047 worth?

The government has obligated $24,837 on 75N92B20P00047.

Was contract 75N92B20P00047 competed?

The extent of competition for 75N92B20P00047 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award